
Stethoscope v. MP3 player
Sweden - According Canadian physician Neil Skjodt a simple MP3 recording device gave a superior performance in auscultation of lung and heart sounds.
Sweden - According Canadian physician Neil Skjodt a simple MP3 recording device gave a superior performance in auscultation of lung and heart sounds.
Toshiba's new Artida Ultrasound system is the world's first ultrasound system that can track and display myocardial wall motion three-dimensionally.
Magnetic Field Imaging (MFI) provides cardiologists with an additional tool to detect arrythmia and irregular cardiac blood flow and thus contributes to a more precise diagnosis. While an ECG acquires electric signals produced by the activity of the cardiac muscle, MFI measures the electrophysical function of the heart by determining the magnetic field during a heartbeat.
Magnetic Field Imaging (MFI) provides cardiologists with an additional tool to detect arrythmia and irregular cardiac blood flow and thus contributes to a more precise diagnosis. While an ECG acquires electric signals produced by the activity of the cardiac muscle, MFI measures the electrophysical function of the heart by determining the magnetic field during a heartbeat.
The Technology initiative “Molecular Imaging” aims to strengthen the synergies of science and industry in research and development of new technologies in order to significantly improve diagnostic and treatment options, for example for cardiovascular diseases, cancer or Alzheimer's.
A compact portable, easy-to-use ECG machine, the MAC 400, was launched in Europe by GE Healthcare at the recent European Society of Cardiology (ESC).
Since the 1950s, the American Heart Association (AHA) has urged a large number of people to take antibiotics before dental work or other procedures that could flood the bloodstream with bacteria. This antibiotic intake was thought to prevent infective endocarditis.
The Eastern Lithuania Cardiology Project (ELCP) - an integral inter-institutional regional project sponsored by the Lithuanian Government and the European Structural Funds, which began in 2004 - will end this year. In May, those who voted on the Lithuanian EU Support official website (a specially organised event, focusing on all EU-supported projects in all fields) nominated this project as the…
The US firm Boston Scientific reports that it has received the Conformité Européenne (CE) Mark for its Confient implantable cardioverter defibrillator (ICD), the company's first branded cardiac rhythm management device to treat sudden cardiac death. Containing wireless capability, the Confient ICD has been designed to reduce right ventricular pacing.
Results of a gender-specific study to assess the efficacy of the Taxus paclitaxel-eluting coronary stent in women undergoing coronary revascularisation were released at the European Society of Cardiology Congress by interventional device developer Boston Scientific.
The Cardiocentro Ticino in Lugano, Switzerland ' a tertiary care centre specialising in treating patients with coronary artery disease ' carries out around 300 major operations and 2,000 invasive coronary angiographies annually. Six months ago, the hospital acquired state-of-the art equipment, including GE's LightSpeed VCT XT.
By Bodo E. Strauer (Düsseldorf, Germany) Russian summary and complete article in English.
Cordis Corporations' CYPHER stent is a Sirolimus-eluting coronary stent used for treatment of patients with coronary artery disease. The five-year results of the E-Sirius Trial show that in comparison to bare metal stents the CYPHER stent offers sustained clinical benefits.
Coronary stents provide wall wrapping of dissection, prevent elastic recoil, and reduce restenosis after percutaneous transluminal coronary angioplasty. In addition, drug eluting stents loaded with antiproliferative agents inhibit intimal hyperplasia and offer a further reduction of restenosis.
Some of the medical procedures and equipment showcased and discussed at the MEDICA 2007 are sure to provide medical experts with plenty of discussion material. In cardiac diagnostic imaging a minor revolution is taking place, with ultrasound procedures increasing in significance. But innovation in x-ray methods is also continuing.
Progenitor cell transfer to repair the damaged heart has emerged as an innovative and promising recent development in cardiovascular medicine.
The Sensei Robotic Catheter System, a first generation robotic platform launched by Hansen Medical at the USA's Heart Rhythm Society Scientific Sessions in May this year, is in use in Europe.
During a meeting of cardiologists in Prague earlier this year to exchange experiences with new methods and treatments to control atrial fibrillation, Dr Josef Kautzner, Head of Cardiology Department at IKEM (Institute of Clinical and Experimental Medicine) pointed out that numbers of patients with AF will more than double during the next 20 years.
An increased TWA (T-wave alternans) is a significant indicator of all-cause and cardiovascular mortality, as well as of sudden cardiac death in patients with mostly normal ejection fraction, according to a recently published study by researchers led by Dr Tuomo Nieminen.
Cardiac infarction and cardiovascular failure are two of today's most frequent emergencies. SCHILLER's FRED® easyport® pocket is the only pocket defibrillator in the world.
More women than men die of cardiovascular disease (CVD) every year, yet females receive only 33% of angioplasties, stents and bypass surgeries; 28% of implantable defibrillators, and 36% of open heart surgeries.
Boston Scientific Corporation has commenced enrolment of a targeted 1,500 patients for the Taxus Perseus clinical trials, planned to take place in 100 international centres.
The Lifebridge B2T (bridge-to-transport) is the first, fully portable emergency life support system for patients suffering cardiogenic shock, or those showing signs of imminent cardiogenic shock.
Cardiac infarction is characterised by tissue ischaemia with loss of contractile heart muscle.
Switzerland - A clinical trial of cardiac resynchronisation therapy (CRT) in patients with advanced heart failure and a narrow QRS complex